nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Diverticulitis—Sunitinib—pancreatic cancer	0.0523	0.0523	CcSEcCtD
Sevelamer—Intestinal perforation—Erlotinib—pancreatic cancer	0.0498	0.0498	CcSEcCtD
Sevelamer—Intestinal perforation—Sunitinib—pancreatic cancer	0.0431	0.0431	CcSEcCtD
Sevelamer—Intestinal perforation—Irinotecan—pancreatic cancer	0.0355	0.0355	CcSEcCtD
Sevelamer—Ileus—Erlotinib—pancreatic cancer	0.0278	0.0278	CcSEcCtD
Sevelamer—Faecaloma—Epirubicin—pancreatic cancer	0.0229	0.0229	CcSEcCtD
Sevelamer—Faecalith—Epirubicin—pancreatic cancer	0.0229	0.0229	CcSEcCtD
Sevelamer—Faecalith—Doxorubicin—pancreatic cancer	0.0212	0.0212	CcSEcCtD
Sevelamer—Faecaloma—Doxorubicin—pancreatic cancer	0.0212	0.0212	CcSEcCtD
Sevelamer—Intestinal obstruction—Irinotecan—pancreatic cancer	0.0206	0.0206	CcSEcCtD
Sevelamer—Ileus—Irinotecan—pancreatic cancer	0.0198	0.0198	CcSEcCtD
Sevelamer—Intestinal obstruction—Docetaxel—pancreatic cancer	0.0142	0.0142	CcSEcCtD
Sevelamer—Ileus—Docetaxel—pancreatic cancer	0.0137	0.0137	CcSEcCtD
Sevelamer—Abdominal distension—Sunitinib—pancreatic cancer	0.0108	0.0108	CcSEcCtD
Sevelamer—Ileus—Epirubicin—pancreatic cancer	0.00924	0.00924	CcSEcCtD
Sevelamer—Abdominal distension—Irinotecan—pancreatic cancer	0.00886	0.00886	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—pancreatic cancer	0.00855	0.00855	CcSEcCtD
Sevelamer—Flatulence—Erlotinib—pancreatic cancer	0.00848	0.00848	CcSEcCtD
Sevelamer—Arthralgia—Tamoxifen—pancreatic cancer	0.0074	0.0074	CcSEcCtD
Sevelamer—Flatulence—Sunitinib—pancreatic cancer	0.00734	0.00734	CcSEcCtD
Sevelamer—Arthralgia—Erlotinib—pancreatic cancer	0.00732	0.00732	CcSEcCtD
Sevelamer—Anorexia—Tamoxifen—pancreatic cancer	0.00676	0.00676	CcSEcCtD
Sevelamer—Anorexia—Erlotinib—pancreatic cancer	0.00669	0.00669	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00646	0.00646	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.0064	0.0064	CcSEcCtD
Sevelamer—Arthralgia—Sunitinib—pancreatic cancer	0.00634	0.00634	CcSEcCtD
Sevelamer—Dyspepsia—Tamoxifen—pancreatic cancer	0.00625	0.00625	CcSEcCtD
Sevelamer—Dyspepsia—Erlotinib—pancreatic cancer	0.00618	0.00618	CcSEcCtD
Sevelamer—Decreased appetite—Tamoxifen—pancreatic cancer	0.00617	0.00617	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00613	0.00613	CcSEcCtD
Sevelamer—Fatigue—Tamoxifen—pancreatic cancer	0.00612	0.00612	CcSEcCtD
Sevelamer—Decreased appetite—Erlotinib—pancreatic cancer	0.0061	0.0061	CcSEcCtD
Sevelamer—Pain—Tamoxifen—pancreatic cancer	0.00607	0.00607	CcSEcCtD
Sevelamer—Constipation—Tamoxifen—pancreatic cancer	0.00607	0.00607	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00606	0.00606	CcSEcCtD
Sevelamer—Fatigue—Erlotinib—pancreatic cancer	0.00605	0.00605	CcSEcCtD
Sevelamer—Flatulence—Irinotecan—pancreatic cancer	0.00604	0.00604	CcSEcCtD
Sevelamer—Pain—Erlotinib—pancreatic cancer	0.006	0.006	CcSEcCtD
Sevelamer—Constipation—Erlotinib—pancreatic cancer	0.006	0.006	CcSEcCtD
Sevelamer—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.0058	0.0058	CcSEcCtD
Sevelamer—Anorexia—Sunitinib—pancreatic cancer	0.00579	0.00579	CcSEcCtD
Sevelamer—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00574	0.00574	CcSEcCtD
Sevelamer—Abdominal pain—Tamoxifen—pancreatic cancer	0.00561	0.00561	CcSEcCtD
Sevelamer—Abdominal pain—Erlotinib—pancreatic cancer	0.00555	0.00555	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00554	0.00554	CcSEcCtD
Sevelamer—Dyspepsia—Sunitinib—pancreatic cancer	0.00535	0.00535	CcSEcCtD
Sevelamer—Decreased appetite—Sunitinib—pancreatic cancer	0.00528	0.00528	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00525	0.00525	CcSEcCtD
Sevelamer—Fatigue—Sunitinib—pancreatic cancer	0.00524	0.00524	CcSEcCtD
Sevelamer—Pain—Sunitinib—pancreatic cancer	0.0052	0.0052	CcSEcCtD
Sevelamer—Constipation—Sunitinib—pancreatic cancer	0.0052	0.0052	CcSEcCtD
Sevelamer—Asthenia—Tamoxifen—pancreatic cancer	0.00509	0.00509	CcSEcCtD
Sevelamer—Arthralgia—Gemcitabine—pancreatic cancer	0.00509	0.00509	CcSEcCtD
Sevelamer—Asthenia—Erlotinib—pancreatic cancer	0.00504	0.00504	CcSEcCtD
Sevelamer—Pruritus—Tamoxifen—pancreatic cancer	0.00502	0.00502	CcSEcCtD
Sevelamer—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00497	0.00497	CcSEcCtD
Sevelamer—Pruritus—Erlotinib—pancreatic cancer	0.00497	0.00497	CcSEcCtD
Sevelamer—Diarrhoea—Tamoxifen—pancreatic cancer	0.00485	0.00485	CcSEcCtD
Sevelamer—Abdominal pain—Sunitinib—pancreatic cancer	0.0048	0.0048	CcSEcCtD
Sevelamer—Diarrhoea—Erlotinib—pancreatic cancer	0.0048	0.0048	CcSEcCtD
Sevelamer—Anorexia—Irinotecan—pancreatic cancer	0.00477	0.00477	CcSEcCtD
Sevelamer—Anorexia—Gemcitabine—pancreatic cancer	0.00465	0.00465	CcSEcCtD
Sevelamer—Anorexia—Fluorouracil—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Sevelamer—Vomiting—Tamoxifen—pancreatic cancer	0.00451	0.00451	CcSEcCtD
Sevelamer—Rash—Tamoxifen—pancreatic cancer	0.00447	0.00447	CcSEcCtD
Sevelamer—Dermatitis—Tamoxifen—pancreatic cancer	0.00447	0.00447	CcSEcCtD
Sevelamer—Vomiting—Erlotinib—pancreatic cancer	0.00446	0.00446	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00444	0.00444	CcSEcCtD
Sevelamer—Rash—Erlotinib—pancreatic cancer	0.00443	0.00443	CcSEcCtD
Sevelamer—Dermatitis—Erlotinib—pancreatic cancer	0.00442	0.00442	CcSEcCtD
Sevelamer—Dyspepsia—Irinotecan—pancreatic cancer	0.00441	0.00441	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00437	0.00437	CcSEcCtD
Sevelamer—Asthenia—Sunitinib—pancreatic cancer	0.00436	0.00436	CcSEcCtD
Sevelamer—Decreased appetite—Irinotecan—pancreatic cancer	0.00435	0.00435	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Sevelamer—Fatigue—Irinotecan—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Sevelamer—Pruritus—Sunitinib—pancreatic cancer	0.0043	0.0043	CcSEcCtD
Sevelamer—Pain—Irinotecan—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Sevelamer—Constipation—Irinotecan—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Sevelamer—Decreased appetite—Gemcitabine—pancreatic cancer	0.00424	0.00424	CcSEcCtD
Sevelamer—Dyspepsia—Fluorouracil—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Sevelamer—Nausea—Tamoxifen—pancreatic cancer	0.00421	0.00421	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00421	0.00421	CcSEcCtD
Sevelamer—Fatigue—Gemcitabine—pancreatic cancer	0.0042	0.0042	CcSEcCtD
Sevelamer—Constipation—Gemcitabine—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Sevelamer—Pain—Gemcitabine—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Sevelamer—Nausea—Erlotinib—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Sevelamer—Decreased appetite—Fluorouracil—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Sevelamer—Diarrhoea—Sunitinib—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00414	0.00414	CcSEcCtD
Sevelamer—Abdominal distension—Epirubicin—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Sevelamer—Pain—Fluorouracil—pancreatic cancer	0.0041	0.0041	CcSEcCtD
Sevelamer—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00409	0.00409	CcSEcCtD
Sevelamer—Abdominal pain—Irinotecan—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Sevelamer—Vomiting—Sunitinib—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Sevelamer—Rash—Sunitinib—pancreatic cancer	0.00383	0.00383	CcSEcCtD
Sevelamer—Dermatitis—Sunitinib—pancreatic cancer	0.00383	0.00383	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Sevelamer—Arthralgia—Docetaxel—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Sevelamer—Nausea—Sunitinib—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Sevelamer—Asthenia—Irinotecan—pancreatic cancer	0.00359	0.00359	CcSEcCtD
Sevelamer—Asthenia—Gemcitabine—pancreatic cancer	0.0035	0.0035	CcSEcCtD
Sevelamer—Pruritus—Gemcitabine—pancreatic cancer	0.00345	0.00345	CcSEcCtD
Sevelamer—Diarrhoea—Irinotecan—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Sevelamer—Pruritus—Fluorouracil—pancreatic cancer	0.00339	0.00339	CcSEcCtD
Sevelamer—Diarrhoea—Gemcitabine—pancreatic cancer	0.00334	0.00334	CcSEcCtD
Sevelamer—Anorexia—Docetaxel—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Sevelamer—Diarrhoea—Fluorouracil—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Sevelamer—Vomiting—Irinotecan—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Sevelamer—Rash—Irinotecan—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Sevelamer—Dermatitis—Irinotecan—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Sevelamer—Vomiting—Gemcitabine—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Sevelamer—Rash—Gemcitabine—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Sevelamer—Dermatitis—Gemcitabine—pancreatic cancer	0.00307	0.00307	CcSEcCtD
Sevelamer—Vomiting—Fluorouracil—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Sevelamer—Dyspepsia—Docetaxel—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Sevelamer—Rash—Fluorouracil—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Sevelamer—Dermatitis—Fluorouracil—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Sevelamer—Decreased appetite—Docetaxel—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Sevelamer—Fatigue—Docetaxel—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Sevelamer—Nausea—Irinotecan—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Sevelamer—Pain—Docetaxel—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Sevelamer—Constipation—Docetaxel—pancreatic cancer	0.00296	0.00296	CcSEcCtD
Sevelamer—Nausea—Gemcitabine—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Sevelamer—Nausea—Fluorouracil—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Sevelamer—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Sevelamer—Flatulence—Epirubicin—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Sevelamer—Abdominal pain—Docetaxel—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Sevelamer—Asthenia—Docetaxel—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Sevelamer—Pruritus—Docetaxel—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Sevelamer—Arthralgia—Epirubicin—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Sevelamer—Diarrhoea—Docetaxel—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Sevelamer—Anorexia—Epirubicin—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Sevelamer—Vomiting—Docetaxel—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Sevelamer—Rash—Docetaxel—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Sevelamer—Dermatitis—Docetaxel—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Sevelamer—Nausea—Docetaxel—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Sevelamer—Dyspepsia—Epirubicin—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Sevelamer—Decreased appetite—Epirubicin—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Sevelamer—Fatigue—Epirubicin—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Sevelamer—Constipation—Epirubicin—pancreatic cancer	0.002	0.002	CcSEcCtD
Sevelamer—Pain—Epirubicin—pancreatic cancer	0.002	0.002	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Sevelamer—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Pain—Doxorubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Sevelamer—Abdominal pain—Epirubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Asthenia—Epirubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Sevelamer—Pruritus—Epirubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Sevelamer—Diarrhoea—Epirubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Sevelamer—Vomiting—Epirubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Sevelamer—Rash—Epirubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Sevelamer—Dermatitis—Epirubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Sevelamer—Nausea—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Sevelamer—Rash—Doxorubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
